Key result
TRIM47 knockdown attenuates pressure overload-induced cardiac hypertrophy and fibrosis by suppressing NLRP3 inflammasome activation.
Why the study?
The ubiquitinated protein TRIM47 participates in the inflammatory regulation of various organ injuries, but its role in pressure overload-induced heart failure remained unclear.
Does myocardial knockdown of TRIM47 attenuate pressure overload-induced myocardial hypertrophy, fibrosis, apoptosis, and NLRP3 inflammasome activation in a TAC mouse model of heart failure?
Does myocardial knockdown of TRIM47 attenuate pressure overload-induced myocardial hypertrophy, fibrosis, apoptosis, and NLRP3 inflammasome activation in a TAC mouse model of heart failure?
In a pressure overload mouse model of heart failure, targeted myocardial knockdown of TRIM47 alleviates cardiac hypertrophy, fibrosis, apoptosis, and left ventricular dysfunction by inhibiting NLRP3 inflammasome activation.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for TRIM47 as a target in pressure-overload HF; human studies required before clinical consideration.
BACKGROUND: The ubiquitinated protein TRIM47 participates in the inflammatory regulation of various organ injuries, but its role in pressure overload-induced heart failure remains unclear. OBJECTIVE: The aim of this study is to investigate the protective effect of TRIM47 knockdown against pressure overload-induced myocardial injury. METHODS: A TAC mouse model of heart failure was established, and myocardial TRIM47 knockdown was achieved through targeted cardiac injection of AAV-sh-TRIM47. Heart weight/body weight ratio (HW/BW) and heart weight/tibia length ratio (HW/TL) were measured, and ANP/BNP mRNA levels were used to assess myocardial injury. HE and WGA staining were used to observe cardiomyocyte hypertrophy; Masson and Sirius red staining were used to detect myocardial fibrosis; TUNEL staining and apoptosis-related protein analysis were used to detect cardiomyocyte apoptosis; and Western blotting was used to detect the expression levels of key molecules in the NLRP3 inflammasome. RESULTS: TRIM47 was highly expressed in the left ventricle of mice with heart failure. In the TAC group, mice showed increased HW/BW and HW/TL ratios, as well as elevated ANP and BNP mRNA levels. Cardiomyocyte hypertrophy, disordered myofiber arrangement, increased collagen deposition and expression of fibrosis-related proteins, and myocardial apoptosis were observed. Increased expression of inflammasome activation-related proteins, including NLRP3, cleaved caspase-1, mature IL-1β, and IL-18 was also observed. Knockdown of TRIM47 reversed these pathological changes. CONCLUSION: TRIM47 is abnormally upregulated in the myocardium in pressure overload-induced heart failure. TRIM47 knockdown alleviates TAC-induced heart failure by inhibiting myocardial hypertrophy, fibrosis, apoptosis, and NLRP3 inflammasome activation.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied Pressure overload-induced heart failure (transverse aortic constriction mouse model) (n=32). Myocardial TRIM47 knockdown via AAV9-sh-TRIM47 vs. Sham operation, TAC alone, or TAC + negative control knockdown virus (AAV-sh-NC) was evaluated on Myocardial hypertrophy, left ventricular hemodynamics, myocardial fibrosis, cardiomyocyte apoptosis, and NLRP3 inflammasome activation at 4 weeks post-TAC (p=<0.001). AAV9-mediated TRIM47 knockdown attenuated TAC-induced myocardial hypertrophy, fibrosis, apoptosis, and NLRP3 inflammasome activation in mice.
Synapse has enriched 10 related papers. Consider them for comparative context: